+987.9%
MRNA vs DBX
+22.5%
+965.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | DBX | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +3.3% | +9.8% | +12.7% |
| 7D | +20.6% | -1.1% | +21.8% | +20.7% |
| 30D | +27.1% | +5.0% | +22.1% | +26.4% |
| 3M | +353.4% | +4.6% | +348.8% | +349.0% |
| 6M | +446.3% | +43.9% | +402.3% | +398.7% |
| YTD | +776.2% | +29.9% | +746.3% | +705.7% |
| 1Y | +987.9% | +24.6% | +963.3% | +900.5% |
| All | +987.9% | +22.5% | +965.4% | +900.5% |
Cumulative growth
Daily Returns
Daily percentage return beside DBX.
Daily Out/Under-Performance
Portfolio return minus DBX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × DBX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded DBX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling